Costs and epidemiological changes of chronic diseases: Implications and challenges for health systems

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Arredondo, Armando ^a   Aviles, Raul ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BUDGET; CASE MANAGEMENT; CHRONIC DISEASE; COST OF ILLNESS; DIABETES MELLITUS; EPIDEMIOLOGICAL DATA; HEALTH CARE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MEDICALLY UNINSURED; MEXICO; PREDICTION; RESOURCE ALLOCATION; RISK FACTOR; SOCIAL SECURITY; ECONOMICS; HEALTH CARE DELIVERY; HEALTH SERVICE; STATISTICS AND NUMERICAL DATA;

CHRONIC DISEASE; DELIVERY OF HEALTH CARE; DIABETES MELLITUS; HEALTH CARE COSTS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; HYPERTENSION; MEXICO;

EID: 84924940439     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118611     Document Type: Article

References (41)

1. Arredondo A, Reyes G (2013) Health Disparities from Economic Burden of Diabetes in Middle-income Countries: Evidence from México. Plos ONE. 8:e68443. doi: 10.1371/journal.pone.0068443 PMID: 23874629
2. Cercone J (2014) Asociación público-privada para la atención a la salud. El desafío de la reforma en salud. Foro de Europa y América sobre las Reformas del Sector Salud. Banco Mundial-IESE, 2:6-11.
3. Villarreal E, Matew-Quiroz A (2002) Costo de la atención de la hipertensión arterial y su impacto en el gasto en salud en México. Sal Pub de Mex. 2002. Vol 44, 2002 (1): 7-13.
4. Amos AF, McCarty D, Zimmet P (2010) The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetes medicine 1997; 14 Suppl 5: 51-85.
5. Quentin T (2013) Poverty and Policy in Latin America and the Caribbean. World Bank Technical Paper ISBN 0-8213-4754- 3: 53-58.
6. Lozano R Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study. Lancet, 380: 2095-2117. doi: 10.1016/S0140-6736(12)61728-0 PMID: 23245604
7. Shaw J, Sicree R, Zimment P (2010) Global estimates of the prevalence of diabetes for 2110 and 2030, Diabetes Res. Clin.Pract. 87: 4-14.
8. Glassman A1, Gaziano TA, Bouillon Buendia CP, Guanais de Aguiar FC (2010). Confronting the chronic disease burden in Latin America and the Caribbean. Health Aff, 29(12):2142-8. doi: 10.1377/hlthaff.2010.1038 PMID: 21134914
9. Gaziano TA (2010) Chronic disease management in Latin America and Caribbean. Background paper prepared for RG-K1041 Prevention and Management of Chronic Disease. Inter-American Development Bank: 54-68.
10. Barcelo A, Aedo C, Rajpathak S, Robles S (2003) The cost of diabetes in Latin America and the Caribbean. Bulletin of the World Health Organization. 81(1):19-27. PMID: 12640472
11. World Health Organization (2009) "Guidelines to assess the social and economic impact consequences of the diseases". Geneva: 37-56.
12. Arredondo A, Aviles R (2014) Hypertension and Its Effects on the Economy of the Health System for Patients and Society: Suggestions for Developing, Am Jou of Hypertension, 27(4): 335-36.
13. Instituto Nacional de Salud Pública (2012) Encuesta Nacional de Salud y Nutrición-2012. Daños y servicios de la salud. Cuernavaca, Mex. INSP-SSA-: 74-81.
14. Elliot W (1996) The costs of treating hypertension: What are the long-term realities of cost containment and pharmacoeconomics? Hypertension and Costs/Posgraduate Medicine, Vol 99 (4): 241-152. PMID: 8604411
15. García C, Thorogood M, Reyes S, Salmerón J, Durán C (2001) The prevalence and treatment of Hypertension in Elderly Population. Sal Pub de Mex, Vol 4(3): 415-420.
16. SSA (2013) Programa Sectorial Salud. Plan Nacional de Desarrollo. Indicadores y Diagnostico. Mexico DF, 2013.
17. Arredondo A, Icaza E (2011) Diabetes health care costs in Latin America: Evidences from México. Value in Health, 14 (9) 85-88.
18. SSA, IMSS, ISSSTE (2014) Boletín de Información Estadística. Casos de morbilidad hospitalaria por demanda específica, 1996-2013. SSA Ed. México, D.F: 57-81
19. SSA (2013) Reporte Anual de Casos de Enfermedades Cronicas. Sistema Único de Información para la Vigilancia Epidemiológica. Dirección General de Epidemiología. SSA. Mexico DF. 1996-2013: 1-2. doi: 10.7334/psicothema2012.167 PMID: 25078753
20. Instituto Nacional de Salud Pública (2014) Métodos de estimación de demanda esperada de enfermedades crónico-degenerativas. Informe Técnico Parcial. Cuernavaca, México.: 34-46.
21. Brealey R. y Stewart M (1993) Fundamentos de financiación empresarial para establecer tasa de descuento. Madrid, Mc Graw-Hill: 43-56. doi: 10.1055/s-0031-1275710 PMID: 21594814
22. Gálvez A (2007) Salud Basada en la Evidencia. Cómo incorporar la investigación cualitativa a la práctica de los cuidados en salud. Estudios de Sombra. Ed. Fundación Index: Granada: 13-26.
23. Murray A (2005) "Statistical Modelling and Statistical Inference: Measurement error in the explanatory variables. Box-Jenkins technique, in Statistical Modelling in GLIM. Oxford Science Publications, Ox. Uni. Press, New York, U.S.A.; Third Ed. Chap.2: 112-132.
24. Snowdon A, Schnarr K, Hussein A, Alessi Ch (2012) Measuring What Matters: The Cost vs. Values of Health Care. International Centre for Health Innovation, Richard Ivey School of Business, Western University. Ontario CA: 12-20.
25. Zhang P, Zhang X, Brown J, Vistisen D, Sicree R (2010) Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Research 87: 293-301. doi: 10.1016/j.diabres.2010.01.026 PMID: 20171754
26. Banco de México (2014) Indice Nacional de Precios por Servicios Médicos en México. Cuadernos Mensuales, Base 2000 = 100. La Actividad Económica en México. 1992-2012. Gerencia de Investigación Económica. Banco de México Ed. México DF, México: 57-81. doi: 10.1016/j.jphotobiol.2014.11.014 PMID: 25535873
27. International Diabetes Federation (2010) Direct cost to the health care sector. Diabetes Health Economics. International Diabetes Federation. Brussels, Belgium: 29-35.
28. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global Prevalence of Diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care, 27(5):1047-1053. PMID: 15111519
29. Johnson S, Delate T, Boka A, Shaw P, Zager C (2013) Characterizing the financial burden of pulmonary arterial hypertension within an integrated healthcare delivery system J Med Econ; 16(12):1414-22. doi: 10.3111/13696998.2013.849713 PMID: 24074226
30. Arredondo A (2013) Diabetes: a global challenge with high economic burden for public health systems and society. Rev. American Journal of Public Health, 2013. Vol. 103. Num 2: e1-e2 doi: 10.2105/AJPH.2012.301106 PMID: 23237161
31. Stevens G, Dias RH, Thomas KJA, Rivera JA, Carvalho N, Barquera S (2008) Characterizing the epidemiological transition in Mexico: national and subnational burden of diseases, injuries, and risk factors. PLoS Med., 5(6):125.
32. Arredondo A., Orozco E, Abis Duperval P, Cuadra M, Cicero M, Hernández C, et al. (2009) "Temas Selectos en Sistemas de Salud: Costos, Financiamiento, Equidad y Gobernanza. Conceptos, Tendencias y Evidencias. Ed Univ. Aut. de Yucatán: 101-112.
33. Aboderin I, Kalache A, Ben-Sholmo Y, Lynch JW, Yajnik CS, Kuh D (2001) Life Course Perspectives on Coronary Heart Disease, Stroke and Diabetes: Key Issues and Implications for Policy and Research. Summary report of a meeting of experts 2-4 May 2001. (WHO/NMH/NPH/01.4) Geneva: WHO: 33-36.
34. Barquera S, Campos I, Aguilar C, Lopez R, Arredondo A, Rivera J (2013) Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policy. Global Health Governance. Vol. 9, no. 3:1744-1752
35. Dos Santos JC, Moreira TM (2012) Risk factors and complications in patients with hypertension/diabetes in a regional health district of northeast Brazil. Rev Esc Enferm USP; 46(5):1125-32. PMID: 23223728
36. Frenk J, Zurita B, Franco F, Arredondo A, Quisser M, Ramírez R (1994) Demanda y oferta de servicios médicos: Obstáculos a la mejoría del sistema de salud en México. FUNSALUD, Proyecto Economía y Salud:18-27.
37. Campos I, Hernández B, Rojas R (2013) Hipertensión arterial: prevalencia, diagnóstico oportuno, control y tendencias en adultos mexicanos. Salud Publica Mex; Vol 55 supl 2:S144-S150
38. Hernández-Ávila M, Gutiérrez JP, Reynoso-Noverón N (2013) Diabetes mellitus en México. El estado de la epidemia. Salud Publica Mex; Vol 55 supl 2:S129-S136
39. Barreto SM, Miranda JJ, Figueroa JP, Schmidt MI, Munoz S, Kuri-Morales PP, et al (2012) Epidemiology in Latin America and the Caribbean: current situation and challenges. Int J Epidemiol; 41(2):557-71. doi: 10.1093/ije/dys017 PMID: 22407860
40. Peckham R (2014) Contagion: epidemiological models and financial crises. J Public Health (Oxf); 36 (1):13-7. doi: 10.1093/pubmed/fdt083 PMID: 23965642
41. Teixeira JC, Gomes MH, Souza JA (2012) Association between sanitation services coverage and epidemiological indicators in Latin America: a study with secondary data Rev Panam Salud Publica; 32 (6):419-25. PMID: 23370185